P 115: Potential Therapeutic Targets Related to Neuroinflammation in Treatment and Prevention of Autism

author

  • Samira Soltanian Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract:

Autism spectrum disorder (ASD) is a mental condition, present from early childhood, characterized by great difficulty in communicating and forming relationships with others and using language. In the last four decades many studies have shown that immune responses in different regions of brain play an important role in ASD pathogenicity. A conservative estimate based on the research suggests that a great percentage of patients with ASD have microglial activation or neuroinflammation. Microglial activation or dysfunction affects neural development and results in neurodevelopmental disorders like ASD. Powerful immune-modulators like poly unsaturated fatty acids (PUFAs) and specially n-3 PUFAs exerting anti-inflammatory properties are important during brain development. Omega-3 fatty acids have an important role in neurogenesis, neurotransmission and protection from oxidative stress. Some of these effects are mediated by inhibiting the formation of prostaglandin E2 from arachidonic acid (an omega-6 PUFA). So PUFA deficiency during pregnancy can cause neurodevelopmental disorders including ASD in children. Considering the fact that most of patients with ASD have neuroinflammation and possibly immune responses in the brain is an important part of ASD emergence, curing the inflammation by inhibiting microglial cells and reducing pro-inflammatory cytokines, can be effective to improve symptoms. A recently published article showed that Fingolimod (FTY720) administration to autism rat models can cause improvement in behavior, learning and memory by inhibiting activation of microglial cells and lowering the level of pro-inflammatory cytokines like interleukin-1β (IL-1β) and IL-6 in the brain and reduces neuronal loss and apoptosis of pyramidal cells in hippocampus. So more studies needed to prove the effect of this drug on the treatment of ASD and finding new ways to inhibit microglial activation to stop neuroinflammation. PUFAs play a vital role in neurodevelopment by immunomodulation so it is suggested that an improved diet including enough amounts of PUFAs during pregnancy can be profoundly effective to prevent ASD in children.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

p 115: potential therapeutic targets related to neuroinflammation in treatment and prevention of autism

autism spectrum disorder (asd) is a mental condition, present from early childhood, characterized by great difficulty in communicating and forming relationships with others and using language. in the last four decades many studies have shown that immune responses in different regions of brain play an important role in asd pathogenicity. a conservative estimate based on the research suggests tha...

full text

P 138: Improving Neuroplasticity Through Neuroinflammation Pathways as a Therapeutic Goal in the Treatment of Autism

Neuroplasticity is the brain's ability to reorganize itself by forming new neural connections throughout life. Neuroplasticity allows the neurons in the brain to compensate injury and disease and to adjust their activities in response to new situations or to changes in their environment. At the other side, it is now well established that neuronal function is strongly influenced by both central ...

full text

p 138: improving neuroplasticity through neuroinflammation pathways as a therapeutic goal in the treatment of autism

neuroplasticity is the brain's ability to reorganize itself by forming new neural connections throughout life. neuroplasticity allows the neurons in the brain to compensate injury and disease and to adjust their activities in response to new situations or to changes in their environment. at the other side, it is now well established that neuronal function is strongly influenced by both cen...

full text

P 107: P2x7 Receptors: as a Novel Targets for the Treatment of Neuroinflammation

P2x7 receptors are Purineric receptors that are extracellular ATP-gated ion channel. These receptors require high dose or prolonged exposure to ATP for initial activation. The Activation of these receptors facilitates the formation of inflammasome which activates caspase 1. The P20 and P10 subunits of caspase 1 form active enzyme that then releases active interleukin (IL)-1 β and IL-18, tu...

full text

P 62: Markers of Neuroinflammation Related to Alzheimer\'s Disease Pathology in the Elderly

Alzheimer Disease (AD) is a neurodegenerative disorder and the most common form of dementia. Increasing evidence suggests that Alzheimer's disease pathogenesis is not restricted to the neuronal compartment, but includes strong interactions with immunological mechanisms in the brain. In vitro and animal studies have linked neuroinflammation to Alzheimer's disease (AD) pathology. Studies on marke...

full text

P 61: MicroRNA as a Therapeutic Tool to Prevent Blood Brain Barrier Dysfunction in Neuroinflammation

Endothelial cells present in brain are unique and differ from other peripheral tissues in a number of ways, which ensures specific brain endothelial barrier properties. Endothelial dysfunction is the earliest event in the initiation of vascular damage caused by inflammation. Various microRNAs (miRNA) have been discovered in different cellular components of the blood bran barrier (BBB). miRNAs a...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 5  issue 2

pages  146- 146

publication date 2017-04

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023